Sun Pharmaceutical Industries Share Price Today - Live Blog for September 22, 2025

Sun Pharmaceutical Industries Ltd share price has declined by -0.20%, and it's currently trading at ₹1,640.00. The stock maintains a PE of 38.3100, while the industry PE is 35.7722, prompting discussions about its valuation.

Sun Pharmaceutical Industries Ltd's stock price surged by 0.08%, reaching the current market value of ₹1,642.90 per share. This surge is a testament to the stock's recent performance.

Sun Pharmaceutical Industries Ltd shares saw a -0.02% decrease, reaching a current market price of ₹1,643.10. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 38.3100, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

Sun Pharmaceutical Industries Ltd's share price has fallen by -0.23%, a situation worth noting. At present, the stock is trading at ₹1,643.15. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 38.3100, while the industry PE ratio is 35.7722.

Sun Pharmaceutical Industries Ltd witnessed a -0.02% drop in its share price and is currently trading at ₹1,646.05. With the stock's PE at 38.3100 and the industry PE at 35.7722, investors are weighing their options.

With a remarkable 0.19% increase in value, the share price of Sun Pharmaceutical Industries Ltd currently stands at ₹1,646.45. Notably, this stock has a Price-to-Earnings (PE) ratio of 38.3100, while the industry's PE ratio is 35.7722.

The stock of Sun Pharmaceutical Industries Ltd is on the rise, registering an impressive 0.18% increase and currently trading at ₹1,645.75 per share. Investors are taking notice of this upward momentum.

Sun Pharmaceutical Industries Ltd's share price has experienced a notable 0.03% upswing, and it's currently trading at ₹1,642.80 per share. Investors are closely watching this development.

Sun Pharmaceutical Industries Ltd witnessed a -0.23% drop in its share price and is currently trading at ₹1,645.50. With the stock's PE at 38.3100 and the industry PE at 35.7722, investors are weighing their options.

With a -0.23% decrease, Sun Pharmaceutical Industries Ltd's share price is now at ₹1,645.50. The stock is currently trading at a PE of 38.3100, while the industry PE is 35.7722, prompting investors to assess its value proposition.

Sun Pharmaceutical Industries Ltd has had quite the run lately, experiencing a substantial 0.17% uptick in its share price. As a result, it's now actively trading at ₹1,650.80 per share, making it an attractive option for investors.

Sun Pharmaceutical Industries Ltd's shares experienced a 0.25% uptick, and they are currently valued at ₹1,647.00, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.0327 and an ROE of 15.1334%.

Sun Pharmaceutical Industries Ltd stock maintained its current value, with no movement, and is trading at ₹1,646.40. The stock has a PE ratio of 38.3100, an ROE of 15.1334%, and a debt to equity ratio of 0.0327.

Sun Pharmaceutical Industries Ltd stock stayed at its current value, with no movement, and is trading at ₹1,646.40. The stock has a PE ratio of 38.3100, an ROE of 15.1334%, and a debt to equity ratio of 0.0327.

Climbing steadily, Sun Pharmaceutical Industries Ltd shares have ascended by 0.05%, reaching the current market price of ₹1,647.50. This ascent signifies increased investor sentiment. The stock has an ROE of 15.1334% and debt to equity ratio of 0.0327.

The share price of Sun Pharmaceutical Industries Ltd remained consistent, showing no variations, and is currently at ₹1,646.40. Investors may choose to delve into the stock's financial health and competitive positioning.

The stock of Sun Pharmaceutical Industries Ltd is making significant strides, boasting a 0.08% increase and currently trading at ₹1,646.45 per share. This upward trajectory is turning heads in the market.

Sun Pharmaceutical Industries Ltd witnessed a -0.15% decrease in its share price, and it is currently trading at ₹1,645.20. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 38.3100, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

Sun Pharmaceutical Industries Ltd witnessed a substantial 0.10% increase in its share price and is currently trading at ₹1,646.55. This remarkable performance has caught the eye of investors.

Climbing steadily, Sun Pharmaceutical Industries Ltd shares have ascended by 0.21%, reaching the current market price of ₹1,644.00. This ascent signifies increased investor sentiment. The stock has an ROE of 15.1334% and debt to equity ratio of 0.0327.

Sun Pharmaceutical Industries Ltd's share price has fallen by -0.02%, a situation worth noting. At present, the stock is trading at ₹1,638.75. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 38.3100, while the industry PE ratio is 35.7722.

Sun Pharmaceutical Industries Ltd experienced a -0.02% downturn in its share price, and it's currently trading at ₹1,638.75. This situation is generating interest among value investors who are evaluating the stock's potential.

After a -0.30% decline, Sun Pharmaceutical Industries Ltd shares are now trading at ₹1,643.00. The stock has a PE ratio of 38.3100, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

Sun Pharmaceutical Industries Ltd stock price decreased by -0.30%, with the current market value at ₹1,643.00 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

Sun Pharmaceutical Industries Ltd's share price has dropped by -0.28%, a development that warrants careful analysis. Presently trading at ₹1,649.00, investors are assessing whether this presents an opportunity or a risk.

Sun Pharmaceutical Industries Ltd's shares experienced a 0.33% uptick, and they are currently valued at ₹1,651.50, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.0327 and an ROE of 15.1334%.